Author: Nicholas Alan Clayton

Roth CH Acquisition II Co. (ROCC) to Combine with Reservoir Holdings in $788M Deal

Roth CH II (NASDAQ:ROCC) has entered into a definitive agreement to combine with independent media company Reservoir Holdings at an enterprise value of $788 million, or 20x its 2022E EBITDA. New York City-based Reservoir is a family-owned music publisher with about 130,000 copyrights, 26,000 master recordings and hundreds of #1 releases. The combined company will
Read More

To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
tango logo

BCTG Acquisition Corp. (BCTG) to Combine with Tango Therapeutics in $353M Deal

BCTG (NASDAQ:BCTG) has entered into a definitive agreement with biotech firm Tango Therapeutics, bringing total proceeds of $353 million into the deal. Tango is developing a range of cancer therapies designed to suppress tumor growth that are currently in pre-clinical stages. The combined company is expected to trade on the Nasdaq under the symbol “TNGX”
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
tpg-pace-beneficial

TPG Pace Beneficial II Corp. (YTPG) Prices $350M IPO

TPG Pace Beneficial II Corp. announced the pricing of its $350 million IPO and its shares are expected to begin trading on the NYSE under the symbol “YTPG” April 14.

 TPG Pace Beneficial II is led by President Michael MacDougall, The new company aims to combine with a target that has strong ESG characteristics that is at an inflection point towards attractive risk-adjusted returns.

...READ MORE
IPO-Pricing

Altimeter Growth Corp. (AGC) to Combine with Grab in $31.2Bn Deal

Altimeter (NASDAQ:AGC) announced this morning that it intends to enter into a definitive agreement to combine with Asian ride-hailing service Grab at a pro forma enterprise value of $31.26 billion, or 26.1x its 2020 revenue. The transaction as proposed is by far the largest SPAC deal to date at nearly double the transaction value of
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
Alert-2
RUMORS

Friday Rumor Roundup: Record-Breaking SPAC Deals Reportedly on the Horizon

The financial press has been aflutter with reports on SPAC deals in the works over the past 24 hours including from big-name SPAC teams. We’ve assembled them here to chew on as we head into the weekend. Ginko Bioworks Soaring Eagle Acquisiton Corp. (NASDAQ:SRNGU) is reportedly nearing a deal to combine with bioengineering firm Ginko
Read More
To access this post, you must purchase 1 - User: Monthly Plan.
TOP-3
IPO-Pricing
IPO-Pricing
tpg-pace-solutions-logo
cellebrite logo

TWC Tech Holdings II (TWCT) to Combine with Cellebrite in $1.8Bn Deal

TWC Tech II (NASDAQ:TWCT) has entered into a definitive agreement to combine with digital intelligence firm Cellebrite at an enterprise value of $1.81 billion, or 9.2x its 2020 revenue. Cellebrite provides a software platform to aid both government investigators and private sector business intelligence departments. The combined company is expected to trade on the Nasdaq
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
IPO-Pricing
Archaea logo

Rice Acquisition Corp. (RICE) to Combine with Aria Energy and Archaea Energy in $1.15Bn Deal

Rice (NYSE:RICE) has entered into a definitive agreement to combine with two natural gas companies – Aria and Archaea Energy – at an enterprise value of $1.15 billion for the pair, or 8.2x their 2022E EBITDA. Archaea and Aria each harvest gases from landfills to refine into green energy sources for electricity or natural gas
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
IPO-Pricing

CA Healthcare Acquisition Corp (CAHC) to Combine with LumiraDx in $5Bn Deal

CA Healthcare (NASDAQ:CAHC) has entered into a definitive agreement to combine with medical device-maker LumiraDx at an enterprise value of $5 billion, or 26.6x its 2020 revenue. LumiraDx has developed a pair of diagnostic systems designed to decentralize testing for a range of conditions including COVID-19. The combined company is expected to trade on the
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.

Mountain Crest Acquisition Corp. II (MCAD) to Combine with Better Therapeutics in $187M Deal

Mountain Crest II (NASDAQ:MCAD) has entered into a definitive agreement to combine with biopharmaceutical firm Better Therapeutics at an enterprise value of $187 million. Better Therapeutics provides prescription digital therapeutics (PDT) that deliver behavior-based therapy to address the root causes of cardiometabolic diseases. The combined company is expected to be listed on the Nasdaq under
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
IPO-Pricing
IPO-Pricing
Mudrick Topps logo

Mudrick Capital Acquisition Corporation II (MUDS) to Combine with Topps in $1.3Bn Deal

Mudrick II (NASDAQ:MUDS) has entered into a definitive agreement to combine with sports and entertainment collectibles company Topps at an enterprise value of $1.3 billion, or 1.9x its 2021E revenue. Topps provides multi-platform collectible sports and entertainment products as well as a line of candies and other snacks. The combined entity is expected to trade
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.